Melanoma exosomes promote mixed M1 and M2 macrophage polarization

• Published in: Cytokine (Philadelphia, Pa.) Vol. 105; pp. 63 - 72
• Main Authors: Bardi, Gina T., Smith, Mary Ann, Hood, Joshua L.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.05.2018
• Subjects: Animals; Arginase - metabolism; Biomarkers - metabolism; Cell Polarity - drug effects; Chemokine; Cytokine; Exosomes; Exosomes - drug effects; Exosomes - metabolism; Gene Expression Regulation - drug effects; Interleukin-4 - metabolism; Lipopolysaccharides - pharmacology; M1/M2; Macrophage; Macrophages - drug effects; Macrophages - metabolism; Macrophages - pathology; Melanoma; Melanoma, Experimental - pathology; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II - metabolism; Polarization; RAW 264.7 Cells; Up-Regulation - drug effects; Chemokine; Polarization; M1/M2; Melanoma; Cytokine; Exosomes; Macrophage
• ISSN: 1043-4666; 1096-0023
• DOI: 10.1016/j.cyto.2018.02.002

•Anti-tumor (M1) and pro-tumor (M2) macrophages influence melanoma survival.•Melanoma exosomes also facilitate tumor survival.•Melanoma exosomes might directly influence M1 or M2 macrophage polarization.•Melanoma exosomes induce a mixed M1/M2 pro-tumor macrophage activation phenotype. Macrophages are key participants in melanoma growth and survival. In general, macrophages can be classified as M1 or M2 activation phenotypes. Increasing evidence demonstrates that melanoma exosomes also facilitate tumor survival and metastasis. However, the role of melanoma exosomes in directly influencing macrophage function is poorly understood. Herein, we investigated the hypothesis that natural melanoma exosomes might directly influence macrophage polarization. To explore this hypothesis, ELISA, RT-qPCR, and macrophage functional studies were performed in vitro using an established source of melanoma exosomes (B16-F10). ELISA results for melanoma exosome induction of common M1 and M2 cytokines in RAW 264.7 macrophages, revealed that melanoma exosomes do not polarize macrophages exclusively in the M1 or M2 direction. Melanoma exosomes induced the M1 and M2 representative cytokines TNF-α and IL-10 respectively. Further assessment, using an RT-qPCR array with RAW 264.7 and primary macrophages, confirmed and extended the ELISA findings. Upregulation of markers common to both M1 and M2 polarization phenotypes included CCL22, IL-12B, IL-1β, IL-6, i-NOS, and TNF-α. The M2 cytokine TGF-β was upregulated in primary but not RAW 264.7 macrophages. Pro-tumor functions have been attributed to each of these markers. Macrophage functional assays demonstrated a trend toward increased i-NOS (M1) to arginase (M2) activity. Collectively, the results provide the first evidence that melanoma exosomes can induce a mixed M1 and M2 pro-tumor macrophage activation phenotype.